Piramal Critical Care
Laura Fecher has a diverse work experience spanning several industries. Laura started their career at CannonDesign in 2001, working in Mechanical Engineering/Operations until 2004. Laura then joined Minrad International Inc. in 2004, where they held various roles, including Document Control Coordinator, Project Manager - Disposables, Director of Engineering - Disposables, and Veterinary Product Manager. In 2008, Laura joined Piramal Critical Care, where they initially served as a Product Manager/Northeast Accounts Manager - Animal Health and later progressed to become a National Accounts Manager. Their most recent role at Piramal Critical Care is Senior Director of National Accounts, US and Canada, which they have been holding since May 2022.
Laura Fecher completed their education at the University at Buffalo. Laura obtained a Bachelor of Science (BS) degree in Mechanical Engineering from 1999 to 2004. Later, they pursued a Master of Business Administration (MBA) degree from the same institution, which they completed from 2001 to 2004. In terms of additional certifications, Laura attended the SLII Workshop at The Ken Blanchard Companies in February 2020. Additionally, they completed the Scotwork Advancing Negotiation Skills program at Scotwork in September 2016.
This person is not in any offices
Piramal Critical Care
Piramal Critical Care (PCC), a business division of Piramal Pharma Limited (PPL) is one of the leaders in inhaled anesthetics and a global player in hospital generics. “Saving and improving patients’ lives” is much more than a purpose statement to us. We are motivated by our vision of commitment to delivering critical care solutions for patients and healthcare providers, while achieving sustainable and profitable growth for all the stakeholders. Piramal Critical Care maintains a wide presence across the US, Europe and more than 100 countries across the globe. Our product portfolio includes inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain and anesthesia drugs, injectable anti-infectives, oral therapy for Type I Gaucher and Niemann pick Type C disease, anticholinergic, plasma volume expander, non-depolarizing neuromuscular blocking agent, depolarizing skeletal muscle relaxant and an anxiolytic, sedative and pain medication. Our products include Sevoflurane, Desflurane, Isoflurane, Halothane, Gablofen® (Baclofen Injection), MITIGO™(Morphine Sulfate), Dipidolor® (Piritramide), Sublimaze® (Fentanyl Citrate), Rapifen® (Alfentanil Hydrochloride), Sufenta® (Sufentanil Citrate), Hypnomidate®(Etomidate), Ampicillin and Sulbactam for Injection, USP, Cefepime for Injection, USP, Ceftriaxone for Injection, USP, Linezolid Injection, Ampicillin for Injection, USP, Piperacillin and Tazobactam for Injection, USP, Yargesa™ (Miglustat), Glycopyrrolate, Haemaccel, Rocuronium Bromide Injection, Succinylcholine Chloride Injection, USP, Dexmedetomidine Injection, USP, Dexmedetomidine HCl in 0.9% Sodium Chloride Injection (RTU*) and Propofol- Lipuro emulsion for Injection or Infusion. PCC has strong manufacturing and process development experience. PCC has fully owned manufacturing facilities in Bethlehem, PA, USA and Digwal, India. Customer centricity is the cornerstone of our business. *RTU Ready to use